chrX-149490313-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000202.8(IDS):c.1006+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000202.8 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- mucopolysaccharidosis type 2Inheritance: XL, AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, PanelApp Australia, Myriad Women’s Health
- mucopolysaccharidosis type 2, attenuated formInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- mucopolysaccharidosis type 2, severe formInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IDS | NM_000202.8 | c.1006+1G>A | splice_donor_variant, intron_variant | Intron 7 of 8 | ENST00000340855.11 | NP_000193.1 | ||
| IDS | NM_001166550.4 | c.736+1G>A | splice_donor_variant, intron_variant | Intron 7 of 8 | NP_001160022.1 | |||
| IDS | NM_006123.5 | c.1006+1G>A | splice_donor_variant, intron_variant | Intron 7 of 7 | NP_006114.1 | |||
| IDS | NR_104128.2 | n.1305+1G>A | splice_donor_variant, intron_variant | Intron 8 of 8 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IDS | ENST00000340855.11 | c.1006+1G>A | splice_donor_variant, intron_variant | Intron 7 of 8 | 1 | NM_000202.8 | ENSP00000339801.6 | |||
| ENSG00000241489 | ENST00000651111.1 | c.373+1G>A | splice_donor_variant, intron_variant | Intron 12 of 13 | ENSP00000498395.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Mucopolysaccharidosis, MPS-II Pathogenic:4Other:1
A hemizygous 3’ splice site variation in intron 7 of the IDS gene that affects the invariant AG acceptor splice site upstream of exon 8 was detected. The observed variant c.1006+1G>A has not been reported in the 1000 genomes and gnomAD databases. The in silico prediction of the variant is damaging by MutationTaster and DANN. In summary, the variant meets our criteria to be classified as pathogenic. -
Null variant (PVS1_VeryStrong), Prevalence of the variant significantly increased in affected individuals compared with controls (PS4_Supporting), Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Patient’s phenotype or family history highly specific for the disease (PP4_Moderate) -
The change c.1006+1G>A is a known splice donor variant. This mutation was due to the substitution of G to A at nucleotide position c.1006+1 in the intron 7 of IDS gene. It was detected in a hemizygous state in one of the patient with severe phenotype from Bihar. It was also reported in databases dbSNP (rs869025308) and HGMD (CX931238). -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at